Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 104

    1.

    The MLL recombinome of acute leukemias in 2013.

    Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, Pombo de Oliveira M, Renneville A, Villarese P, Macintyre E, Cavé H, Clappier E, Mass-Malo K, Zuna J, Trka J, De Braekeleer E, De Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VH, van Dongen JJ, Delabesse E, Binato R, Silva ML, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V, Heidenreich O, Vormoor J, Choi WW, Jarosova M, Kolenova A, Bueno C, Menendez P, Wehner S, Eckert C, Talmant P, Tondeur S, Lippert E, Launay E, Henry C, Ballerini P, Lapillone H, Callanan MB, Cayuela JM, Herbaux C, Cazzaniga G, Kakadiya PM, Bohlander S, Ahlmann M, Choi JR, Gameiro P, Lee DS, Krauter J, Cornillet-Lefebvre P, Te Kronnie G, Schäfer BW, Kubetzko S, Alonso CN, Zur Stadt U, Sutton R, Venn NC, Izraeli S, Trakhtenbrot L, Madsen HO, Archer P, Hancock J, Cerveira N, Teixeira MR, Lo Nigro L, Möricke A, Stanulla M, Schrappe M, Sedék L, Szczepański T, Zwaan CM, Coenen EA, van den Heuvel-Eibrink MM, Strehl S, Dworzak M, Panzer-Grümayer R, Dingermann T, Klingebiel T, Marschalek R.

    Leukemia. 2013 Apr 30. doi: 10.1038/leu.2013.135. [Epub ahead of print]

    PMID:
    23628958
    [PubMed - as supplied by publisher]
    2.

    At diagnosis, diffuse large B-cell lymphoma patients show impaired rituximab-mediated NK-cell cytotoxicity.

    Danielou-Lazareth A, Henry G, Geromin D, Khaznadar Z, Briere J, Tamouza R, Cayuela JM, Thieblemont C, Toubert A, Dulphy N.

    Eur J Immunol. 2013 Apr;43(5):1383-8. doi: 10.1002/eji.201242733. Epub 2013 Mar 11.

    PMID:
    23400905
    [PubMed - in process]
    3.

    Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.

    Jourdan E, Boissel N, Chevret S, Delabesse E, Renneville A, Cornillet P, Blanchet O, Cayuela JM, Recher C, Raffoux E, Delaunay J, Pigneux A, Bulabois CE, Berthon C, Pautas C, Vey N, Lioure B, Thomas X, Luquet I, Terré C, Guardiola P, Béné MC, Preudhomme C, Ifrah N, Dombret H; French AML Intergroup.

    Blood. 2013 Mar 21;121(12):2213-23. doi: 10.1182/blood-2012-10-462879. Epub 2013 Jan 15.

    PMID:
    23321257
    [PubMed - indexed for MEDLINE]
    4.

    Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study.

    Tanguy-Schmidt A, Rousselot P, Chalandon Y, Cayuela JM, Hayette S, Vekemans MC, Escoffre M, Huguet F, Réa D, Delannoy A, Cahn JY, Vernant JP, Ifrah N, Dombret H, Thomas X.

    Biol Blood Marrow Transplant. 2013 Jan;19(1):150-5. doi: 10.1016/j.bbmt.2012.08.021. Epub 2012 Sep 6.

    PMID:
    22960387
    [PubMed - in process]
    5.

    Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.

    Kreutzman A, Jaatinen T, Greco D, Vakkila E, Richter J, Ekblom M, Hjorth-Hansen H, Stenke L, Melo T, Paquette R, Seggewiss-Bernhardt R, Guerci-Bresler A, Talbot A, Cayuela JM, Mahon FX, Porkka K, Lipton J, Partanen J, Rousselot P, Mustjoki S.

    Exp Hematol. 2012 Nov;40(11):906-913.e1. doi: 10.1016/j.exphem.2012.07.007. Epub 2012 Jul 25.

    PMID:
    22842045
    [PubMed - indexed for MEDLINE]
    6.

    Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ⁻/⁻ mice.

    Patel S, Zhang Y, Cassinat B, Zassadowski F, Ferré N, Cuccuini W, Cayuela JM, Fenaux P, Bonnet D, Chomienne C, Louache F.

    Leukemia. 2012 Nov;26(11):2432-5. doi: 10.1038/leu.2012.154. Epub 2012 Jun 13. No abstract available.

    PMID:
    22699451
    [PubMed - indexed for MEDLINE]
    7.

    Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma.

    Bégué E, Jean-Louis F, Bagot M, Jauliac S, Cayuela JM, Laroche L, Parquet N, Bachelez H, Bensussan A, Courtois G, Michel L.

    Blood. 2012 Jul 5;120(1):143-54. doi: 10.1182/blood-2011-09-379156. Epub 2012 May 24.

    PMID:
    22627769
    [PubMed - indexed for MEDLINE]
    8.

    Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.

    Gandemer V, Chevret S, Petit A, Vermylen C, Leblanc T, Michel G, Schmitt C, Lejars O, Schneider P, Demeocq F, Bader-Meunier B, Bernaudin F, Perel Y, Auclerc MF, Cayuela JM, Leverger G, Baruchel A; FRALLE Group.

    Haematologica. 2012 Nov;97(11):1743-50. doi: 10.3324/haematol.2011.059584. Epub 2012 May 11.

    PMID:
    22580999
    [PubMed - in process]
    Free PMC Article
    9.

    First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia.

    Rea D, Etienne G, Nicolini F, Cony-Makhoul P, Johnson-Ansah H, Legros L, Huguet F, Tulliez M, Gardembas M, Bouabdallah K, Rousselot P, Cayuela JM, Guilhot F, Mahon FX.

    Leukemia. 2012 Oct;26(10):2254-9. doi: 10.1038/leu.2012.92. Epub 2012 Mar 30.

    PMID:
    22460758
    [PubMed - indexed for MEDLINE]
    10.

    Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.

    Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, Gardin C, Cayuela JM, Hayette S, Reman O, Contentin N, Bordessoule D, Pautas C, Botton Sd, Revel Td, Terre C, Fenaux P, Thomas X, Castaigne S, Dombret H, Preudhomme C.

    Leukemia. 2012 Jun;26(6):1247-54. doi: 10.1038/leu.2011.382. Epub 2012 Jan 13.

    PMID:
    22289988
    [PubMed - indexed for MEDLINE]
    11.

    Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation.

    Coude MM, Luycx O, Cariou ME, Maarek O, Dombret H, Cayuela JM, Rea D.

    Br J Haematol. 2012 May;157(3):407-10. doi: 10.1111/j.1365-2141.2011.09016.x. Epub 2012 Jan 9. No abstract available.

    PMID:
    22225474
    [PubMed - indexed for MEDLINE]
    12.

    Free amino acid content of goat's milk cheese made with animal rennet and plant coagulant.

    Abellán A, Cayuela JM, Pino A, Martínez-Cachá A, Salazar E, Tejada L.

    J Sci Food Agric. 2012 Jun;92(8):1657-64. doi: 10.1002/jsfa.5528. Epub 2011 Dec 22.

    PMID:
    22190174
    [PubMed - indexed for MEDLINE]
    13.

    Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.

    Konopacki J, Porcher R, Robin M, Bieri S, Cayuela JM, Larghero J, Xhaard A, Andreoli AL, Dhedin N, Petropoulou A, Rodriguez-Otero P, Ribaud P, Moins-Teisserenc H, Carmagnat M, Toubert A, Chalandon Y, Socie G, Peffault de Latour R.

    Haematologica. 2012 May;97(5):710-6. doi: 10.3324/haematol.2011.050096. Epub 2011 Dec 16.

    PMID:
    22180425
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.

    Balgobind BV, Hollink IH, Arentsen-Peters ST, Zimmermann M, Harbott J, Beverloo HB, von Bergh AR, Cloos J, Kaspers GJ, de Haas V, Zemanova Z, Stary J, Cayuela JM, Baruchel A, Creutzig U, Reinhardt D, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM.

    Haematologica. 2011 Oct;96(10):1478-87. doi: 10.3324/haematol.2010.038976. Epub 2011 Jul 26.

    PMID:
    21791472
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial.

    Millot F, Baruchel A, Guilhot J, Petit A, Leblanc T, Bertrand Y, Mazingue F, Lutz P, Vérité C, Berthou C, Galambrun C, Bernard F, Yacouben K, Bordigoni P, Edan C, Reguerre Y, Couillault G, Méchinaud F, Cayuela JM, Guilhot F.

    J Clin Oncol. 2011 Jul 10;29(20):2827-32. doi: 10.1200/JCO.2010.32.7114. Epub 2011 Jun 13.

    PMID:
    21670449
    [PubMed - indexed for MEDLINE]
    16.

    Antioxidant activity and phenolic compounds in organic red wine using different winemaking techniques.

    Mulero J, Zafrilla P, Cayuela JM, Martínez-Cachá A, Pardo F.

    J Food Sci. 2011 Apr;76(3):C436-40. doi: 10.1111/j.1750-3841.2011.02104.x.

    PMID:
    21535811
    [PubMed - indexed for MEDLINE]
    17.

    Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.

    Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M, Vuerhard M, Buijs-Gladdines J, Kooi C, Klous P, van Vlierberghe P, Ferrando AA, Cayuela JM, Verhaaf B, Beverloo HB, Horstmann M, de Haas V, Wiekmeijer AS, Pike-Overzet K, Staal FJ, de Laat W, Soulier J, Sigaux F, Meijerink JP.

    Cancer Cell. 2011 Apr 12;19(4):484-97. doi: 10.1016/j.ccr.2011.02.008.

    PMID:
    21481790
    [PubMed - indexed for MEDLINE]
    18.

    Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases.

    Ruggeri A, Peffault de Latour R, Carmagnat M, Clave E, Douay C, Larghero J, Cayuela JM, Traineau R, Robin M, Madureira A, Ribaud P, Ferry C, Devergie A, Purtill D, Rabian C, Gluckman E, Toubert A, Socié G, Rocha V.

    Transpl Infect Dis. 2011 Oct;13(5):456-65. doi: 10.1111/j.1399-3062.2011.00632.x. Epub 2011 Apr 5.

    PMID:
    21466640
    [PubMed - indexed for MEDLINE]
    19.

    Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost?

    Cayuela JM, Macintyre E, Darlington M, Abdelali RB, Fund X, Villarese P, Tulliez M, Raffoux E, Sigaux F, Réa D, Seror V.

    Haematologica. 2011 May;96(5):664-71. doi: 10.3324/haematol.2010.034389. Epub 2011 Feb 17.

    PMID:
    21330326
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).

    Deau B, Nicolini FE, Guilhot J, Huguet F, Guerci A, Legros L, Pautas C, Berthou C, Guyotat D, Cony-Makhoul P, Gardembas M, Michallet M, Hayette S, Cayuela JM, Weiss IR, Réa D, Castaigne S, Mahon FX, Guilhot F, Rousselot P.

    Leuk Res. 2011 Jun;35(6):777-82. doi: 10.1016/j.leukres.2010.11.004. Epub 2010 Dec 10.

    PMID:
    21145590
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk